Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA |
NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% |
1,537,279 (+61.04%) |
Filing History |
| 2023-02-14 4:35 pm Unchanged |
2022-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
NEXTECH VI ONCOLOGY SCSP | 1,910,029 2.000% |
0 (Unchanged) |
Filing History |
| 2021-09-27 4:36 pm Purchase |
2021-09-17 | 13G | Tyra Biosciences, Inc. TYRA |
NEXTECH VI ONCOLOGY SCSP | 2,518,582 5.900% |
2,518,582 (New Position) |
Filing History |
| 2021-02-16 4:01 pm Purchase |
2020-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
NEXTECH VI ONCOLOGY SCSP | 1,910,029 5.500% |
1,910,029 (New Position) |
Filing History |